Publications by authors named "Revathi Badiginchala"
Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension (NDLS) versus Conventional Docetaxel as Neoadjuvant and Adjuvant Therapy for Primary Operable Breast Cancer.
Revathi Badiginchala Palanki Satya Dattatreya Attili Venkata Satya Suresh Sharanabasappa Somanath Nirni Vindhya Vasini Andra
Onco Targets Ther
April 2023
Objective: Nanosomal docetaxel lipid suspension (NDLS) is a novel formulation developed to overcome toxicity issues caused by excipients (polysorbate 80 and ethanol) present in commercially available docetaxel formulation. We conducted a prospective, observational study to compare the outcomes of nanosomal docetaxel lipid suspension (NDLS)-based versus conventional docetaxel-based chemotherapy in primary operable breast cancer.
Methods: Sixty adult women with newly diagnosed stage IIb-III breast cancer were included.